Fraction 4 (55.7 mg, eluted with light petroleum - EtOAc 80 20) was subjected to PTLC (silica gel, mobile phase methylene chloride - EtOAc 99 1) to yield 16.5 mg 2 (tschimganin).
Fraction 6 (66 mg, eluted with light petroleum - EtOAc 70 30) was subjected to PTLC (silica gel, mobile phase methylene chloride - EtOAc 99 1) and gave two pure compounds: 2.8 mg of 1 (suberosin) and 2.7 mg of 3 (tschimgin).
Fraction 15 (11.3 mg, eluted with light petroleum - EtOAc 45:55) was further purified by PTLC (silica gel, mobile phase methylene chloride - EtOAc 20 1, two-fold development) to afford 5.8 mg ferutinin 4 and 2.1 mg teferin 5.
The dry light petroleum extract was subjected to flash chromatography on silica gel, mobile phase light petroleum - EtOAc (ethyl acetate) (100% light petroleum to 100% EtOAc) and 10 fractions (A - J) were obtained.
We investigated the relative contributions of both freely mobile fluid and gel fluid to interstitial fluid pressure by performing simultaneous, real-time fluid-pressure measurements with both the classical wick-in-needle method (to estimate free-fluid pressure) and a piezoelectric pressure catheter transducer (which is capable of capturing pressures associated with either phase).
The obtained supernatant was applied to radio-thin-layer chromatography (radio-TLC silica gel plates, mobile phase acetonitrile/water 70/30 v/v, application volume 2 μL on origin) and analysed via a Canberra-Packard Instant Imager.
In this case, the VPT is triggered by ionic repulsion forces induced by charging of weak acidic or basic groups inside the gel with mobile counter ions, like hydronium or hydroxide ions [13].
Our aim of the present study was to achieve important separations of biosurfactants making TLC green by using environmental friendly mobile phase and silica gel modified with ionic liquid as stationary phase.
(c) The better resolved spots of surfactants (SC, SDC and STC; R F = 0.48, 0.89 and 0.03) from their three-component mixture were realised with M2 mobile phase and silica gel G impregnated with 5%(aq) 1-methylimidazolium chloride (S4) stationary phase.
Nevertheless, injected gel or mobile nanoparticles may dissolve from the intramedullary destination, while solid bioactive implant coatings may reduce this effect.
